Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
Análisis: Teva cae cerca de un 0,20% en el premarket | IG España
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Kare Schultz, president and chief executive officer of Teva... Fotografía de noticias - Getty Images
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
Phillip Frost, billionaire and chairman of Teva Pharmaceutical... Fotografía de noticias - Getty Images
Teva Considers 10,000 Job Cuts - Bloomberg
America's Most Beloved Pharmaceutical Stock Is Israel's Teva - Bloomberg
Teva, AbbVie may pay billions to settle opioid lawsuits
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
Zantac Cancer Case in US Settles for $500,000 (PRGO, TEVA) - Bloomberg
Soriot not moving to Teva - Bloomberg - Globes
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
The Pharma Job From Hell: Low Salary to Fix Sinking Giant Teva - Bloomberg
